Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» hepatitis B
hepatitis B
Antios rocked as hepatitis B safety signal sparks clinical hold, termination of collaboration
Fierce Biotech
Wed, 05/25/22 - 10:34 am
Antios
hepatitis B
Assembly Biosciences
FDA
J&J ends hepatitis B and HPV portions of Bavarian Nordic collab
Endpoints
Mon, 05/9/22 - 10:33 am
JNJ
Janssen
Bavarian Nordic
vaccines
hepatitis B
HPV
Xbiome acquires live biotherapeutic product program targeting ulcerative colitis
Biopharma Reporter
Thu, 04/28/22 - 10:39 pm
Xbiome
microbiome
hepatitis B
artificial intelligence
ulcerative colitis
Finch clips wings of hepatitis B program, hitting pause on clinical plan to focus on C. diff and autism
Fierce Biotech
Fri, 04/1/22 - 10:38 am
Finch Therapeutics
hepatitis B
microbiome
clinical trials
autism
C. difficile
Aligos Takes Another Hit with Halt of Hep B Therapy
BioSpace
Wed, 03/23/22 - 10:31 am
Aligos Therapeutics
hepatitis B
ALG-020572
adverse events
clinical trials
Gilead to limit 340B discounts for hepatitis C drugs
Beckers Hospital Review
Wed, 03/16/22 - 11:28 pm
Gilead Sciences
340B
hepatitis B
Aligos says stop right now to lead hep B med after fruitless phase 1 data
Fierce Biotech
Thu, 01/6/22 - 11:56 pm
Aligos Therapeutics
hepatitis B
clinical trials
VBI Vaccines Gets FDA Approval for First Three-Antigen Hepatitis B Shot
Xtalks
Tue, 12/7/21 - 10:46 am
VBI Vaccines
FDA
hepatitis B
vaccines
PreHevbrio
Antios, months after series B, raises a further $75M to fuel pursuit of hepatitis B cure
Fierce Biotech
Wed, 11/3/21 - 10:46 am
Antios
hepatitis B
ATI-2173
funding
Race for hepatitis B drug intensifies as Antios raises $96m for phase 2 trial
Pharmaforum
Tue, 04/13/21 - 10:18 am
Antios
funding
hepatitis B
ATI-2173
Drug Farm bags $56M to take novel hepatitis B drug into humans
Fierce Biotech
Tue, 02/9/21 - 11:28 am
Drug Farm
hepatitis B
funding
drug development
Gilead & Vir Announce Collaboration To Find Cure For Hepatitis B Virus
NASDAQ
Tue, 01/12/21 - 11:01 am
Gilead Sciences
Vir Biotechnology
hepatitis B
clinical trials
Assembly Bio's hepatitis B program flops as a potential cure in PhII, sending shares spiraling
Endpoints
Sat, 11/7/20 - 11:06 pm
Assembly Biosciences
hepatitis B
clinical trials
vebicorvir
New data from J&J, Arrowhead mark latest step in RNAi's hepatitis B race
BioPharma Dive
Sat, 08/29/20 - 11:42 pm
Arrowhead Pharmaceuticals
JNJ
clinical trials
RNAi
hepatitis B
J&J's RNAi suppresses hepatitis B for 48 weeks after last dose
Fierce Biotech
Fri, 08/28/20 - 10:47 am
JNJ
RNAi
JNJ-3989
hepatitis B
Ionis deal delivers for GSK as HBV drug hits the mark in phase 2
Pharmaforum
Fri, 08/28/20 - 10:36 am
GSK
antisense
hepatitis B
clinical trials
GSK3228836
Ionis Pharmaceuticals
EASL 2020 – Assembly finds a partner as hepatitis B inches forward
EP Vantage
Fri, 08/28/20 - 10:34 am
EASL
RNAi
hepatitis B
Assembly Biosciences
Abrutus
JNJ
GSK
Vir Biotechnology
Dicerna guides Roche-partnered hepatitis B drug past early test
Fierce Biotech
Thu, 08/6/20 - 10:15 am
Roche
Dicerna Pharmaceuticals
hepatitis B
RG6346
clinical trials
Roche drops hep B antiviral as late-stage pipeline tests 'largely on track' despite COVID-19 disruption
Fierce Biotech
Thu, 07/23/20 - 11:12 am
Roche
antiviral
hepatitis B
RG6217
BeiGene expands pipeline and hops on board a quest to cure hep B, inking a $540M deal with a fellow upstart biotech
Endpoints
Mon, 07/20/20 - 10:29 am
China
BeiGene
Assembly Biosciences
hepatitis B
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »